Cancer · Austria
Endometrial cancer
How is it diagnosed today? Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.7 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Hysterectomy, then radiotherapy or chemo if needed. MedlinePlus
4 medicines are approved for this disease in Austria:
- Dostarlimab (Jemperli) – approved in 2021
- Durvalumab (Imfinzi) – approved in 2018
- Olaparib (Lynparza) – approved in 2014
- Pembrolizumab (Keytruda, Keytruda Qlex) – approved in 2015
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (3)
- Cisplatin (Cisplatine Teva, Cisplatine Viatris) – approved for it in France
- Hydroxyprogesterone caproate (Hydroxyprogesterone Caproate) – approved for it in the US
- Lenvatinib (Lenvima, Lenvatinib Sandoz, Lenvatinib-Teva) – approved for it in the US and Switzerland
Being tested in people
7 open trials in Austria, 341 worldwide. See the trials
- Anlotinib hydrochloride capsule + TQB2450 injection (Phase 3)
- anti-PD1 agent therapy - 1 year (Phase 3)
- anti-PD1 agent therapy - 2 years (Phase 3)
- Bevacizumab (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 1 was in animals and 0 in the lab. See them
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters. You can also show trials abroad.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Not labelled yetImpact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.Obstet Gynecol Int · 2026-11-08
- In animalsKeratin 17 drives endometrial cancer aggressiveness via epithelial-mesenchymal transition: a single-cell transcriptomic and integrative bioinformatics study.J Cancer Res Clin Oncol · 2026-08-12
- In peopleSingle-port robotic surgery versus laparo-endoscopic single-site surgery for the surgical staging of early-stage endometrial cancer: a sequential-period propensity-score analysis.J Robot Surg · 2026-11-09
- Not labelled yetTransvaginal ultrasound-based deep learning radiomics for preoperative identification of non-endometrioid endometrial carcinoma: A multicenter study.Clin Imaging · 2026-10-30
- Not labelled yetLong-term oncologic outcomes of pulmonary metastasectomy for lung-confined recurrent endometrial cancer: a single-institution case series.AJOG Glob Rep · 2026-10-07
Not labelled yet: PubMed has not indexed the article yet, so we do not guess.
More research on the disease pageIs it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- ENGAGe - European Network of Gynaecological Cancer Advocacy Groups (ESGO)
ESGO network of 80+ gynaecological cancer patient groups; member list with country filter.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- International Gynecologic Cancer Advocacy Network
Advocacy network of the International Gynecologic Cancer Society: annual advocacy summit, education, advocacy directory; free patient education for survivors and carers
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.